Calyno high oleic soybean oil has been launched by Calyxt Inc. Calyno oil contains approximately 80% oleic acid and up to 20% less saturated fatty acids compared to commodity soybean oil as well as zero grams of trans fat per serving. It has up to three times the fry life and extended shelf life compared to commodity oils.
“This historical commercialization of the first-ever gene-edited food product is a testament that food manufacturers and consumers are not only embracing innovation, but also willing to pay a premium for products which are healthier and traceable to the source,” said Manoj Sahoo, Chief Commercial Officer at Calyxt. “Our next focus is scaling up the supply chain so that we can meet the growing demand for healthier High Oleic Soybean Oil not only for small and mid-sized food manufacturers, but also for global Consumer Packaged Goods (CPG) brands.”
Calyno oil is produced in the U.S., thanks to Calyxt’s partnership with more than 100 farmers in the Upper Midwest region growing over 34,000 acres of Calyxt High Oleic Soybean. After assessment of the soybean, the crop received met Calyxt quality requirements for high oleic and non-GMO.
“Over the past eight years, we’ve remained committed to the American people, evolving the nutrition of food and protecting the environment in order to deliver health-conscious ingredients that tackle food-related health challenges,” said Jim Blome, CEO of Calyxt. “With this milestone, Calyxt has delivered on its promise and progressed from a research and development platform to a full-scale food ingredient company.”
This sale is in alignment with Calyxt’s high quality standards and applicable USDA and FDA requirements.
The Calyxt High Oleic Soybean Meal is also available as a premium non-GMO feed ingredient.